JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305327200 on June 20, 2003

J. Biol. Chem., Vol. 278, Issue 36, 34286-34290, September 5, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34286    most recent
M305327200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maiorino, M.
Right arrow Articles by Flohé, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maiorino, M.
Right arrow Articles by Flohé, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Distinct Promoters Determine Alternative Transcription of gpx-4 into Phospholipid-Hydroperoxide Glutathione Peroxidase Variants*

Matilde Maiorino {ddagger} §, Margherita Scapin {ddagger}, Fulvio Ursini {ddagger}, Mariangela Biasolo ¶, Valentina Bosello {ddagger} and Leopold Flohé ||

From the {ddagger}Department of Biological Chemistry, Viale G. Colombo 3, University of Padova and Department of Histology, Microbiology, and Medical Biotechnology, Via A. Gabelli 63, University of Padova, I-35121 Padova, Italy and the ||Department of Biochemistry, Technical University of Braunschweig, Mascheroder Weg, 1, D-38124 Braunschweig, Germany

Received for publication, May 21, 2003 , and in revised form, June 16, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
A nuclear variant of phospholipid-hydroperoxide glutathione peroxidase (PHGPx, GPx-4) was considered to be derived from alternative pre-mRNA splicing in testis and to regulate sperm maturation. The genomic sequence of rat gpx-4 was established and investigated in respect to expression into the cytosolic, mitochondrial, and nuclear forms of PHGPx. In silico analysis suggested the presence of two distinct promoter regions, the upstream one leading to transcripts translating into cPHGPx or mPHGPx and the downstream one yielding nPHGPx. The promoter activity of both regions was verified by luciferase-based reporter constructs in A7r5 and H9c2 cells. The data reveal that the formation of nPHGPx is due to alternative transcription and not to alternative splicing. Transcripts encoding nPHGPx were most abundant in testis although not restricted to this organ. This observation points to a general role of the nuclear PHGPx variant in regulating cell division.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The family of glutathione peroxidases (GPxs)1 comprises different gene products with a conserved catalytic triad composed of (seleno)cysteine, tryptophan, and glutamine (1). They reduce hydroperoxides to corresponding alcohols at the expense of thiols, typically of glutathione (GSH). The rate constant k+1 of the selenocysteine-containing congeners for the reaction with hydroperoxides, in the range of 105 to 107 M1, is fast enough to cope with oxidant production in cells. Therefore, Se-GPxs are commonly considered to play a key role in cellular antioxidant defense. The best studied members of the family are cellular glutathione peroxidase (cGPx) (GPx-1; EC 1.11.1.9 [EC] ), a tetrameric enzyme known since 1957 (2), and phospholipid-hydroperoxide glutathione peroxidase (PHGPx) (GPx-4; EC 1.11.1.12 [EC] ), a monomeric variant discovered in 1982 (3). cGPx is primarily responsible for the detoxification of H2O2, as is evident from knock-out experiments showing that the cGPx–/– mouse, although vital, is more sensitive to redox-cycling herbicides and other pro-oxidant challenges (46). Furthermore, the observation that Se-deficient or -supplemented cGPx–/– mice exhibit a similar survival curve supports the concept of cGPx as unique in protecting against oxidative stress (7). PHGPx has a broader substrate specificity, which also covers complex hydroperoxides such as phospholipid and cholesterol hydroperoxides (8). It was therefore considered to synergistically act with vitamin E in protecting membranes from lipid peroxidation (9). More recently, however, PHGPx has been implicated in regulating the synthesis of lipid mediators by silencing 5- and 15-lipoxygenase (1012), in suppressing hydroperoxide-induced apoptosis (13), in dampening cytokine-induced gene activation (14), in peroxynitrite scavenging (15), and in spermatogenesis (16).

Several observations indeed point to a specific function of PHGPx in testis: (i) PHGPx activity in this tissue is higher than in any somatic tissue (17); (ii) expression of the corresponding gene, gpx-4, correlates with the abundance of maturating germ cells (18); (iii) expression level is under indirect control of gonadotropins (18); (iv) in mature spermatozoa it is found as an oxidatively inactivated protein that represents a major component of the mitochondrial capsule (1619); (v) chimeric animals hemizygous for gpx-4 show mosaic testicular athrophy and abnormal sperm morphology (20) (vi) rescued enzymatic activity in clinical sperm samples correlates with fertility-related parameters (21); and (vii) promoter mutations in gpx-4 were detected in infertile subjects (22). More recently a selenoprotein band of 34 kDa, detected in testis (23), has been identified as a PHGPx variant with an N-terminal extension that comprises a nuclear targeting signal (24). This sperm nuclei, PHGPx ("sn GPx" in Ref. 24), is proposed to be involved in chromatin condensation and thereby to determine the differentiation of spermatogenic cells into spermatozoa (24).

How the nuclear PHGPx (nPHGPx) is formed is still debated. The PHGPx gene is composed of eight exons that, depending on species, are spread over 3 to 4 kb of DNA. It is transcribed into mRNAs of different lengths (2527), which lead to three different isoforms differing in their N-terminal extensions: a cytosolic one (cPHGPx), a mitochondrial one (mPHGPx), and nPHGPx. cPHGPx and mPHGPx are derived from the same exon (designated 1A; see Fig. 1) by use of different translation starts, whereas the N-terminal extension of nPHGPx results from translation of an alternative exon (designated 1B; see Fig. 1). This phenomenon was first explained as resulting from alternative pre-mRNA splicing by Pfeifer et al. (24). The concept of splicing was also followed through by others (28). In the meantime, Moreno et al. (26) provided strong evidence for the existence of a second promoter that is located in the first intron and creates multiple transcription starts, including the alternative exon 1B, which is spliced to exons 2–7 and translated into nPHGPx. Attempts failed, however, to prove the activity of this alternative promoter region in reporter gene-transfected somatic cells (26, 27). This was interpreted by Borchert et al. (27) to support the original idea of alternative splicing of a transcript derived from the "joint basic promoter" upstream of exon 1A, whereas Moreno et al. (26), argue that the supposed alternative promoter is not recognized in somatic cells because it likely depends on transcription factors regulating nPHGPx expression specifically in germ cells.



View larger version (7K):
[in this window]
[in a new window]
 
FIG. 1.
Schematic representation of rat gpx-4 and supposed promoters. The large boxes represent exons. The two alternative exons yielding the cytosolic plus the mitochondrial (exon 1A) and the nuclear (exon 1B) transcripts are shown in blue and purple, respectively. The uppermost 5'-UTRs of the mitochondrial and nuclear transcripts determined by RACE technology are indicated by small boxes (blue and purple, respectively). Position +1 is the translation start of the mitochondrial transcript; the other positions shown were used for reporter gene constructs (see also Fig. 2). The red squares enclose the promoter areas as proposed by in silico analysis.

 



View larger version (14K):
[in this window]
[in a new window]
 
FIG. 2.
Activity of supposed gpx-4 promoters by reporter gene analysis. Fragments analyzed for reporter gene activity contained only the first promoter (–547 to –30); were extended to include the area of the second supposed promoter also (–547 to +422, –313 to +422, –179 to +422); or contained only the area of the supposed second promoter (+39 to +422, +86 to +422, +86 to +649). Constructs are shown on the right, and colors are as described in the legend for Fig. 1.

 
We describe here reporter gene experiments revealing the activity of the homologous alternative promoter of rat gpx-4 even in somatic cell lines. We further detected nPHGPx-encoding transcripts not only in testis but also in somatic cells and tissues, which opens up the perspective of a potential role for nPHGPx in the regulation of cell division beyond germ line differentiation.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Cloning Rat gpx-4 —Rat gpx-4 was isolated with rat Genome Walker Kits (Clontech, Palo Alto, CA) using the adaptor-ligated rat libraries provided and primers based on known rat cDNA. The entire gpx-4 sequence from –1497 to +2691 was finally elucidated by PCR using pfu polymerase, genomic DNA of Wistar rats (TRIzol reagent, Invitrogen) as template, and primers designed to generate overlapping amplicons (forward, 5'-ctcctccaggggtcagaaaaata-3', reverse, 5'-ctcacgcagccgaccaatgga-3'; forward, 5'-ggccaataagagacgtcag-3', reverse, ccaggcaaaccatgtgc; forward, 5'-tgcacgaattctcagcca-3', reverse, 5'-acaaggcagccaaggtga-3'). PCR conditions were 95 °C for 2 min, 95 °C for 40 s, 61 °C for 40 s, 74 °C for 3 min (40 cycles); and 74 °C for 5 min. Products were separated by agarose gel electrophoresis, and appropriate bands were cut out and sequenced.

Cell Culture—The rat thoracic aorta smooth muscle cell line A7r5 and the rat myoblast H9c2 cell line were grown in Dulbecco's modified Eagle's medium as described (29, 30) but supplemented with 50 nM sodium selenite.

Determination of the 5'-ends of gpx-4 Transcripts—The 5'-ends of PHGPx mRNAs were obtained by RACE cDNA amplification (SMART RACE cDNA amplification kit, Clontech) starting from total RNA of liver, heart, testis, and H9c2 cells. RNA was prepared using the RNeasy Mini-kit (Qiagen, Hilden, Germany) and retrotranscribed into 5'-RACE-ready cDNA samples of 1 µg each. The first 5'-RACE PCRs were performed with reverse primers targeting exon 1A (5'-caggccaggcacagccagag-3') or exon 1B (5'-caggaactcgtggctgttgctggtct-3') to gain the cytosolic and mitochondrial or nuclear transcripts, respectively. For the second amplification, nested reverse primers for exon 1A or 1B (5'-tgctggcttcaataagcggctcagac-3' or 5'-gttgaaaggctcgggaatgggct-3', respectively) were used. The agarose gel-purified RACE products were TA-cloned and sequenced.

Amplification of Rat Testis PHGPx mRNA—120 ng of retrotranscribed RNA was amplified (PCR master mix, Promega, Milano, Italy) in the presence of 8% dimethyl sulfoxide and 0.8 µm of the following primers for the mitochondrial transcript: reverse, 5'-gctgagaattcgtgcatgga-3', and forward, 5'-tccattggtcggctgcgt-3', or forward, 5'-agggcgggcaagccagac-3', or forward, 5'-attcaggcttcccattgg-3' or forward, 5'-ggcaacctcgcggataactg-3'); and for the nuclear transcript: reverse, 5'-atgcacacaagcccagga-3', and forward, 5'-ctgaacaaggccaggcct-3', or forward, 5'-tcggttagctagagtagg-3', or forward, 5'-tgggttactgggacctag-3'. The annealing temperature was 59 °C. Any genomic contamination of the retrotranscribed sample was ruled out by PCR with gpx-4-specific primers annealing to exons 1A and 4: forward, 5'-cctcgcgcgtccattggtcgg-3'; reverse, 5'-ccttgggctggactttcat-3').

Real-time PCR Measurements—Total RNA was again extracted using the RNeasy Mini-kit. Genomic contamination was ruled out as described above. Only samples with an A260/280 nm ratio of 1.8 were accepted.

Standard plasmids were prepared by TA cloning of PCR products obtained from rat testis cDNA with the following primers: forward, 5'-cctcgcgcgtccattgg-3', reverse, 5'-ccaggcaaaccatgtgc-3' (for the cytosolic/mitochondrial transcript); or forward, 5'-tctgctgcaggaccttccc-3, reverse, 5'-gctgagaattcgtgcatgga-3' (for the nuclear transcript). After propagation in Escherichia coli, plasmids containing the correct insert were purified (Plasmid Midi-kit, Qiagen) and quantified by A260 measurements.

Six hundred ng of RNA was retrotranscribed using the Taqman reverse transcription reagents kit (Applied Biosystems, Branchburg, NJ). Amplification was performed on an ABI PRISM 7007 sequence detection system (PE Applied Biosystems, Foster City, CA) and analyzed by Sybr green PCR core reagents (PE Applied Biosystems, Warrington, UK). The amplification mixture for nuclear transcript contained 3 mM MgCl2, 0.2 µM primers (forward, 5'-tctgctgcaggaccttccc-3'; reverse, 5'-gctgagaattcgtgcatgga-3') and serial dilutions of the retrotranscription mixture (1.5–15 ng of starting RNA). Standard reagents were adapted to a final volume of 25 µl. Amplification conditions were: 95 °C, 10 min; 95 °C, 15 s, and 63 °C, 1 min for 40 cycles. The amplification conditions of the cytosolic/mitochondrial transcripts were identical except for the concentration of MgCl2 (2 mM), the primers (0.4 µM; forward, 5'-ttattgaagccagcactgctgt-3'; reverse, 5'-gaattcgtgcatggagcgc-3'), and the annealing/extension temperature (65 °C).

Reporter Gene Experiments—Fragments of gpx-4 were generated by PCR with genomic DNA as template and gpx-4-specific primers and cloned into the KpnI/BglII site of the promoterless pGL3-Basic luciferase reporter vector (Promega). The primers were designed to yield the fragments –547 to –30, –547 to +422, –313 to +422, –179 to +422, +39 to +422, +86 to +422, and +86 to +649. The accuracy of the constructs was verified by sequencing.

Cells were seeded onto 24-well plates, grown to 70% confluence, and transfected with 0.2 µg of the above constructs and appropriate control vectors (pGLBasic vector for negative control and pRL-TK vector expressing Renilla luciferase (Promega) for control of transfection efficiency) using ExGen 500 (MBI-Fermentas, St. Lech-Rot, Germany). Cells were cotransfected with 0.2 µg of one of the above experimental constructs or 0.2 µg of empty vector. After a 24-h expression period, cell lysates were assayed for luciferase activity by the Dual-luciferase Reporter Assay System (Promega) on a plate-reading luminometer (Fluoroskan Ascent FL, Labsystem, Helsinki, Finland). Firefly luciferase activity of the experimental constructs was normalized by the Renilla luciferase activity obtained with the control vector pRL-TK and expressed as amplification factor in respect to the basic luminescence observed with pGLBasic/pRL-TK-transfected cells.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Gene Organization—The overall organization of the rat PHGPx gene, gpx-4, which has been cloned here for the first time, appears to be essentially identical to that previously reported for mouse (31) and humans (32). It complies with the assumption that the coding region is constituted by 7 exons, the first one existing in two alternative forms that encode different proteins (Fig. 1). If exon 1A is translated starting from position +1, mPHGPx is formed, which, upon cleavage of the targeting sequence during intake into the mitochondrion, becomes indistinguishable from the cPHGPx (33, 34). Alternatively, translation can start at a downstream ATG just before the exon 1A/intron 1 boundary to yield cPHGPx. If exon 1B is used with a translation start at + 417, a different N terminus results, which, after 84 amino acids residues, transits into the typical PHGPx sequence due to translation of exons 2–7 with an unchanged reading frame, as described by Pfeifer et al. (24), thus yielding the nuclear variant.

A difference from the previously reported sequences of the N-terminal extension was observed. The sequence 12QCAGIRPYGP21 (24) is replaced here by 12CRQ14; this diversity was detected independently by others2 and thus is likely common. Otherwise, the total genomic sequence now established, –1497 to + 2714 (not shown; GenBankTM accession no. AJ537598 [GenBank] ), is remarkably congruent with published cDNAs (25) and partial genomic sequences (24). Just the insertion of a gctccgg motif upstream of the translation start of mPHGPx, if compared with the mRNA reported by Puspha-Rekka et al. (25), deserves to be mentioned.

An in silico analysis of the entire rat gpx-4 sequence from –1497 to + 2714 by the Genomatix PromoterInspector program (available at www.genomatix.de) suggested two distinct promoter areas (Fig. 1). The most upstream one corresponds in sequence and location to the promoter first identified by Huang et al. (35) in human GPX-4 and confirmed to be active by Maiorino et al. (22) and Borchert et al. (27). Being upstream of exon 1A, it may reasonably be presumed to regulate the products derived from this exon, i.e. cPHGPx and mPHGPx. The second promoter option is located in the first intron upstream of the alternative exon 1B. It is homologous to the mouse promoter postulated by Moreno et al. (26) to regulate the expression of nPHGPx, which depends on the transcription of exon 1B. This hypothetical promoter comprises 308 nucleotides that, according to MatInspector (36), contain 29 putative binding sites for transcription factors or regulatory proteins with a core similarity of 1 and an "optimized" matrix similarity. With identical criteria, a further 17 putative binding sites were identified in the region 340 nucleotides upstream of the putative promoter. In contrast to the corresponding region of the mouse gpx-4, no testis-specific regulatory elements were suggested in this area by the MatInspector program.

Typical splice sites that might yield an mRNA translating into nPHGPx, as suggested by Pfeifer et al. (24) and Borchert et al. (27), could not be detected irrespective of the assumed transcription start.

Proof of Second Promoter Activity—Left with no reasonable source to explain nPHGPx formation by alternative splicing and encouraged by the in silico prediction of the two promoters in gpx-4, we decided to reinvestigate the promoter activities with conventional luciferase-based reporter gene constructs and to test them in homologous, i.e. rat, mesenchymal cell lines.

Expectedly, the sequence –547 to –30 comprising the canonical upstream promoter only was active in both the embryonic rat heart myoblast line H9c2 and the smooth muscle cell line A7r5 (Fig. 2). If the whole stretch from –547 up to the translation start of exon 1B was lined to the reporter gene, activity declined to about 50% in both cell lines, suggesting that downstream elements bind inhibitory ligands. The removal of sequences upstream of the predicted promoter did not significantly affect the results. So far, the data is in line with the canonical promoter being localized in front of exon 1A. The constructs, starting at + 39 and + 86, however, which totally lack the canonical promoter, also showed significant activity in H9c2 cells, whereas in the A7r5 cells their activity was marginal. Furthermore, in both cell lines, increased activity was observed by including exon 1B almost completely into the construct lacking the canonical promoter (+86 to +649). These findings validate the prediction of the PromoterInspector program and, for the first time, unambiguously demonstrate that the hypothetical second promoter of gpx-4 is active in a cell type-dependent manner.

Detection of Exon 1B-derived Transcripts—As expected, the RACE technology applied to mRNA isolated from whole testis detected transcripts corresponding to both exons 1A and 1B (Table I). The 1B transcript extended 14 bases into the 5'-UTR, which agrees perfectly with the major transcription start region at –12 to –14 upstream of the AUG translation site of nPHGPx, worked out by Moreno et al. (26) for the mouse system. Surprisingly, however, an identical transcript could also be detected with mRNA isolated from heart and liver. This clearly indicates that the use of the alternate promoter is not restricted to germ line cells, and accordingly, nPHGPx is not a testis-specific protein.


View this table:
[in this window]
[in a new window]
 
TABLE I
5'-UTR of PHGPx transcripts as determined by RACE analysis of the mRNA

Exon 1A-derived transcripts are shown in capital letters and exon 1B-derived transcripts in small letters. The translational start(s) of the mitochondrial, cytosolic, or nuclear transcripts are highlighted in boldface, boldface italics, and italics, respectively.

 

In the H9c2 cells, which had been shown to use the alternate promoter efficiently, a similar and two additional RACE products were obtained, indicating additional transcription sites at –18, –73, and –108 relative to the nuclear translation start, which complies with the additional upstream transcription sites detected in the mouse system (26). Under our conditions, probing testis mRNA for the region upstream to exon 1A or 1B by reverse transcription PCR with suitable reverse primers and a series of forward primers nesting further 5' to the uppermost transcription start sites identified for each exon product by RACE, a corresponding series of the correct-sized bands was observed (Fig. 3). This suggests that, in both cases, transcription may be initiated even further upstream than suggested by RACE experiments.



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 3.
Reverse transcription PCR analysis of the PHGPx transcripts 5'-ends. The 5'-ends of the transcripts of exon 1A and 1B or mPHGPx and nPHGPx mRNA, respectively (lanes 1–4 and A–C), were probed with a series of forward primers annealing 5' to the uppermost transcription start as identified by RACE technology (see below). As template retrotranscribed, total mRNA from testis was used. Reverse primers were within exon 2 for mPHGPx and at the boundary of exons 1B and 2 for nPHGPx, respectively. Lanes are as follows: 1, forward primer annealing to the gpx-4 position –50 to –33; 2, –81 to –64; 3, –166 to –149; 4, –313 to –290; A, +236 to +253; B, +174 to +191; C, +86 to +103. L marks the molecular weight ladder. For either transcript, no signal was detected using primers annealing further 5' upstream than –313 to –290 and +86 to +103 (not shown). See "Experimental Procedures" for other details.

 

In agreement with previous observations (25, 33), some of the exon 1A-derived transcripts identified here (Table I) do not cover the translational start of the mitochondrial PHGPx. This observation leaves open the possibility that the expression of gpx-4 into mPHGPx or cPHGPx, respectively, is also determined by alternative transcription and not only by an alternative use of the translation start site.

Quantitative Transcript Analysis by Real-time PCR—Transcripts encoding the exon 1A-derived products cPHGPx and mPHGPx and the 1B-derived nPHGPx were detectable by real-time PCR in somatic cell lines and all tissues investigated, i.e. testis as well as brain, heart, liver, and kidney. In each case nPHGPx transcript level were substantially lower than those encoding the cytosolic and mitochondrial forms (Table II). In terms of percentage of total PHGPx transcripts, the nPHGPx transcript varied between 17% in testis and 0.4% for the A7r5 cell line that had shown low activity of the alternative promoter region. The data reveals that nPHGPx is most abundantly expressed in testis in terms of both, absolute and relative amounts, but transcription of gpx-4 into nPHGPx-encoding mRNA is not restricted to spermatogenic cells.


View this table:
[in this window]
[in a new window]
 
TABLE II
Quantitation of the PHGPx transcripts by real time PCR

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
The controversy about the mechanism of nPHGPx transcription can now be settled with a high degree of accuracy. The original proposal (24, 27, 28), which assumes nPHGPx to result from alternate splicing, conflicts with the 5'-UTR sequences of nPHGPx-encoding transcripts (Table I). None of them starts with a 5'-end corresponding to any known sequence upstream of exon 1A, and the genomic gpx-4 sequence upstream of the identified 5'-ends of the transcription starts do not contain any splice sites that could reasonably yield the sequences of the identified transcripts, as similarly argued by Moreno et al. (26) for the mouse system. Instead, multiple transcription start sites similar to those of the mouse system were identified here immediately and further upstream of the translation start site of exon 1B (Table I, Fig. 3), strongly supporting the concept that nPHGPx results from the use of an alternate promoter located in intron 1. The argument made in favor of the alternative splicing concept, that the intron region upstream of exon 1B does not display any promoter activity (27), is invalidated by the demonstration of such activity in H9c2 cells (Fig. 2). Furthermore, our data suggest the presence of downstream elements, increasing novel promoter activity, within exon 1B. The failure to detect the promoter activity of the intron region preceding exon 1B (26, 27) is likely explained by its relatively low and variable response in somatic cells, which is reflected in the relative and absolute low abundance of pertinent transcripts in tissues other than testis (Table II) and/or by the use of heterologous systems for reporter gene experiments in the previous work (26, 27). In short, therefore, translation of gpx-4 into nPHGPx instead of cPHGPx or mPHGPx is caused by the use of distinct transcriptional initiation sites under cell type-specific regulation by an alternate promoter and not by alternative splicing.

The abundance of gpx-4 transcripts in testis underscores the relevance of the PHGPx to spermatogenesis and spermiogenesis, and indeed all of the three different forms may be equally important. Morphological alterations of spermatozoa, as were reported for hemizygous mice (20) and clinical sperm samples of infertile patients (21, 37), are best explained by the role of PHGPx as a structural protein of the mitochondrial capsule in sperm. Although only cPHGPx were detected in the capsule material (16), both mPHGPx and cPHGPx may be considered to provide the raw material for the capsule formation, because these two forms can no longer be distinguished after processing. However the oligospermia consistently observed in transgenic animals (20), in severely selenium-deficient experimental animals (38), and in infertile males with low PHGPx content in sperm (21, 37) points to a distinct role for the active enzyme in earlier stages of spermatogenesis, the PHGPx form involved being unclear. The appearance of nPHGPx in late spermiogenesis (24, 26, 28) coincides with DNA condensation. The ability of PHGPx to act on -SH groups of protamine as alternate substrates (24, 39) prompted the idea that its nuclear variant is indispensable for chromatin condensation by cross-linking protamine thiols. This process is also considered to guarantee appropriate sperm function and arrest of proliferation, once the germ line cells have reached their final state of differentiation (24, 26).

Under consideration for this postulated role of nPHGPx in sperm differentiation, its ubiquitous expression documented here may offer a key to understanding the essential nature of PHGPx in embryonic development. Surprisingly, all efforts to obtain homozygous PHGPx (–/–) mice have failed thus far.3 This outcome of gene disruption experiments cannot be explained by any of the established roles of PHGPx. Knock-out of gpx-1 and gpx-2 yielded offspring with a mild phenotype. GPx-1 (–/–) mice developed normally and displayed no phenotype whatsoever as long as they were not oxidatively challenged. Appropriate controls demonstrated that GPx-1 is the GPx variant that dominates antioxidant defense (40), revealing that a disturbed hydroperoxide metabolism cannot account for prenatal lethality. Similarly, the gastrointestinal GPx-2 could be knocked out without impairing development. Even when cross-bred with GPx-1 (–/–) mice, the resulting double knock-out mice were vital and only later developed an intestinal inflammatory syndrome (41). It is thus extremely unlikely that PHGPx, which is less abundant than any of its congeners, is of vital importance because of its antioxidant potential. Modulation of cytokine responses, as reported for gpx-4 overexpression, cannot likely be reconciled with embryogenesis either, because it has been similarly reported for GPx-1 (42), and needless to say, the role of PHGPx as a structural protein of spermatozoa is irrelevant to embryonic development. Rather a unique role of PHGPx in cellular differentiation would be compatible with the outcome of the reverse genetics approach. The use of protamine -SH groups as an alternate substrate of PHGPx, as demonstrated for testis (39, 24), might be taken as a model for a more general principle of how the enzyme might regulate cell division, and the nuclear form would surely be predestined to fulfill such demands.


    FOOTNOTES
 
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EBI Data Bank with accession number(s) AJ537598 [GenBank] .

* This work was supported by the MIUR (Ministero dell'Istruzione, dell'Universitá e della Ricerca) Cofin 2002 (to F. U.) and Deutsche Forschungsgemeinschaft Grant Fl 61/12-2 (to L. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

§ To whom correspondence should be addressed. Tel.: 39-049-8276103; Fax: 39-049-8073310; E-mail: matilde.maiorino{at}unipd.it.

1 The abbreviations used are: GPxs, glutathione peroxidases; cGPx, cellular glutathione peroxidase; PHGPx, phospholipid-hydroperoxide glutathione peroxidase; cPHGPx, cytosolic PHGPx; mPHGPx, mitochondrial PHGPx; nPHGPx, nuclear PHGPx; RACE, rapid amplification of cDNA ends; UTR, untranslated region. Back

2 R. Brigelius-Flohé, personal communication. Back

3 M. Brielmeyer, personal communication. Back


    ACKNOWLEDGMENTS
 
We thank Prof. G. Palú (Department of Histology, Microbiology, and Medical Biotechnology of the University of Padova) for providing the facility for real-time PCR measurements.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Maiorino, M., Aumann, K. D., Brigelius-Flohé, R., Doria, D., van den Heuvel, J., McCarthy, J., Roveri, A., Ursini, F., and Flohé, L. (1995) Biol. Chem. Hoppe-Seyler 376, 651–660[Medline] [Order article via Infotrieve]
  2. Mills, G. C. (1957) J. Biol. Chem. 229, 189–197[Free Full Text]
  3. Ursini, F., Maiorino, M., Valente, M., Ferri, L., and Gregolin, C. (1982) Biochim. Biophys. Acta 710, 197–211[Medline] [Order article via Infotrieve]
  4. de Haan, J. B., Bladier, C., Griffiths, P., Kelner, M., O'Shea, R. D., Cheung, N. S., Bronson, R. T., Silvestro, M. J., Wild, S., Zheng, S. S., Beart, P. M., Hertzog, P. J., and Kola, I. (1998) J. Biol. Chem. 273, 22528–22536[Abstract/Free Full Text]
  5. Fu, Y., Cheng, W. H., Porres, J. M., Ross, D. A., and Lei, X. G. (1999) Free Radic. Biol. Med. 27, 605–611[CrossRef][Medline] [Order article via Infotrieve]
  6. Jaeschke, H., Ho, Y. S., Fisher, M. A., Lawson, J. A., and Farhood, A. (1999) Hepatology 29, 443–450[CrossRef][Medline] [Order article via Infotrieve]
  7. Cheng, W. H., Ho, Y. S., Valentine, B. A., Ross, D. A., Jr. Combs, G. F., and Lei, X. G. (1998) J. Nutr. 128, 1070–1076[Abstract/Free Full Text]
  8. Thomas, J. P., Maiorino, M., Ursini, F., and Girotti, A. W. (1990) J. Biol. Chem. 265, 454–461[Abstract/Free Full Text]
  9. Maiorino, M., Coassin, M., Roveri, A., and Ursini, F. (1989) Lipids 24, 721–726[CrossRef][Medline] [Order article via Infotrieve]
  10. Weitzel, F., and Wendel, A. (1993) J. Biol. Chem. 268, 6288–6292[Abstract/Free Full Text]
  11. Schnurr, K., Belkner, J., Ursini, F., Schewe, T., and Kuhn, H. (1996) J. Biol. Chem. 271, 4653–4658[Abstract/Free Full Text]
  12. Imai, H., Narashima, K., Arai, M. Sakamoto, H., Chiba, N., and Nakagawa, Y. (1998) J. Biol. Chem. 273, 1990–1997[Abstract/Free Full Text]
  13. Nomura, K., Imai, H. Koumura, T. Arai, M., and Nakagawa, Y. (1999) J. Biol. Chem. 274, 29294–29302[Abstract/Free Full Text]
  14. Brigelius-Flohé, R., Friedrichs, B., Maurer, S., Schultz, M., and Streicher, R. (1997) Biochem. J. 328, 199–203[Medline] [Order article via Infotrieve]
  15. Sies, H., Sharov, V. S., Klotz, L. O., and Briviba, K. (1997) J. Biol. Chem. 272, 27812–27817[Abstract/Free Full Text]
  16. Ursini, F., Heim, S., Kiess, M., Maiorino, M., Roveri, A., Wissing, J., and Flohé, L. (1999) Science 285, 1393–1396[Abstract/Free Full Text]
  17. Roveri, A., Casasco, A., Maiorino, M., Dalan, P., Calligaro, A., and Ursini, F. (1992) J. Biol. Chem. 267, 6142–6146[Abstract/Free Full Text]
  18. Maiorino, M., Wissing, J. B., Brigelius-Flohé, R., Calabrese, F., Roveri, A., Steinert, P., Ursini, F., and Flohé, L. (1998) FASEB J. 12, 1359–1370[Abstract/Free Full Text]
  19. Mauri. P. L., Benazzi, L., Flohé, L., Maiorino, M., Pietta, P. G., Pilawa, S., Roveri, A., and Ursini, F. (2003) Biol. Chem. 384, 575–588[CrossRef][Medline] [Order article via Infotrieve]
  20. Conrad, M., Heinzmann, U., Wurst, W., Bornkmamm, G. W., and Brielmeier, M. (2000) in 7th International Symposium on Selenium, Abstr. 34, Cooperativa Libraria Editrice Universitá di Padova (CLEUP), Padova, Italy
  21. Foresta, C., Flohé, L., Garolla, A., Roveri, A., Ursini, F., and Maiorino, M. (2002) Biol. Reprod. 67, 967–971[Abstract/Free Full Text]
  22. Maiorino, M., Bosello, V., Ursini, F., Foresta, C., Garolla, A., Scapin, M., Sztajer, H., and Flohé, L. (2003) Biol. Reprod. 68, 1134–1141[Abstract/Free Full Text]
  23. Behne, D., Kyriakopoulos, A., Kalcklosch, M., Weiss-Nowak, C., Pfeifer, H., Gessner, H., and Hammel, C. (1997) Biomed. Environ. Sci. 10, 340–345[Medline] [Order article via Infotrieve]
  24. Pfeifer, H., Conrad, M., Roethlein, D., Kyriakopoulos, A., Brielmeier, M., Bornkmamm, G. W., and Behne, D. (2001) FASEB J. 15, 1236–1238[Free Full Text]
  25. Pushpa-Rekha, T. R., Burdsall, A. L., Oleksa, L. M., Chisolm, G. M., and Driscoll, D. M. (1995) J. Biol. Chem. 270, 26993–26999[Abstract/Free Full Text]
  26. Moreno, S. G., Laux, G., Brielmeyer, M., Bornkamm, G. W., and Conrad, M. (2003) Biol. Chem., 384, 635–643[CrossRef][Medline] [Order article via Infotrieve]
  27. Borchert, A., Savaskan, N. E., and Kuhn, H. (2003) J. Biol. Chem. 278, 2571–2580[Abstract/Free Full Text]
  28. Puglisi, R., Tramer, F., Panfili, E., Micali, F., Sandri, G., and Boitani, C. (2003) Biol. Reprod. 68, 405–411[Abstract/Free Full Text]
  29. Minotti, G., Ronchi, R., Salvatorelli, E., Menna, P., and Cairo, G. (2001) Cancer Res. 61, 8422–84228[Abstract/Free Full Text]
  30. Roveri, A., Coassin, M., Maiorino, M., Zamburlini, A., Van Amsterdam, F. Th. M., Ratti, E., and Ursini, F. (1992) Arch. Biochem. Biophys. 297, 265–270[CrossRef][Medline] [Order article via Infotrieve]
  31. Borchert, A., Schnurr, K., Thiele, B. J., and Kuhn, H. (1999) FEBS Lett. 446, 223–227[CrossRef][Medline] [Order article via Infotrieve]
  32. Kelner, M. J., and Montoya, M. A. (1998) Biochem. Biophys. Res. Commun. 249, 53–55[CrossRef][Medline] [Order article via Infotrieve]
  33. Arai, M., Imai, H., Sumi, D., Imanaka, T., Takano, T., Chiba, N., and Nakagawa, Y. (1996) Biochem. Biophys. Res. Commun. 227, 433–439[CrossRef][Medline] [Order article via Infotrieve]
  34. Roveri, A., Maiorino, M., Nisii, C., and Ursini, F. (1994) Biochim. Biophys. Acta 1208, 211–221[CrossRef][Medline] [Order article via Infotrieve]
  35. Huang, H. S., Chen, C. J., and Chang, W. C. (1999) FEBS Lett. 455, 111–116[CrossRef][Medline] [Order article via Infotrieve]
  36. Quandt, K., Frech, K., Karas, H., Wingender, E., and Werner, T. (1995) Nucleic Acids Res. 23, 4878–4884[Abstract/Free Full Text]
  37. Imai, H., Suzuki, K, Ishizaka, K., Ichinose, S., Oshima, H., Okayasu, I., Emoto, K., Umeda, M., and Nakagawa, Y. (2001) Biol. Reprod. 64, 674–683[Abstract/Free Full Text]
  38. Wallace, E., Calvin, H. I., Ploetz, K., and Cooper, G. W. (1987) in Selenium in Biology and Medicine, Part A (Combs, J. F., Jr., Levander, O. A., Spallholz, J. E., and Oldfield, J. E., eds) pp. 181–196, AVI Publishing Co., Westport, CT
  39. Godeas, C., Tramer, F., Micali, F., Soranzo, M., Sandri, G., and Panfili, E. (1997) Biol. Reprod. 57, 1502–1508[Abstract]
  40. Brigelius-Flohé, R., Maiorino, M. Ursini, F., and Flohé, L. (2002) in Handbook of Antioxidants, Biochemical, Nutritional and Clinical Aspects (Cadenas, E., and Packer, L., eds) pp. 633–664, Marcel Dekker, New York
  41. Esworthy, R. S., Aranda, R., Martin, M. G., Doroshow, J. H., Binder, S. W., and Chu, F. F. (2001) Am. J. Physiol. 281, G848–G855
  42. Kretz-Remy C., Mehlen, P., Mirault, M. E., and Arrigo, A. P. (1996) J. Cell Biol. 133, 1083–1093[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Genes Dev.Home page
C. Ufer, C. C. Wang, M. Fahling, H. Schiebel, B. J. Thiele, E. E. Billett, H. Kuhn, and A. Borchert
Translational regulation of glutathione peroxidase 4 expression through guanine-rich sequence-binding factor 1 is essential for embryonic brain development
Genes & Dev., July 1, 2008; 22(13): 1838 - 1850.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. Puglisi, A. Bevilacqua, G. Carlomagno, A. Lenzi, L. Gandini, M. Stefanini, F. Mangia, and C. Boitani
Mice Overexpressing the Mitochondrial Phospholipid Hydroperoxide Glutathione Peroxidase in Male Germ Cells Show Abnormal Spermatogenesis and Reduced Fertility
Endocrinology, September 1, 2007; 148(9): 4302 - 4309.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Walshe, M. M. Serewko-Auret, N. Teakle, S. Cameron, K. Minto, L. Smith, P. C. Burcham, T. Russell, G. Strutton, A. Griffin, et al.
Inactivation of Glutathione Peroxidase Activity Contributes to UV-Induced Squamous Cell Carcinoma Formation
Cancer Res., May 15, 2007; 67(10): 4751 - 4758.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
O. Mittapalli, J. J. Neal, and R. H. Shukle
Antioxidant defense response in a galling insect
PNAS, February 6, 2007; 104(6): 1889 - 1894.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
H. Imai, M. Saito, N. Kirai, J. Hasegawa, K. Konishi, H. Hattori, M. Nishimura, S. Naito, and Y. Nakagawa
Identification of the Positive Regulatory and Distinct Core Regions of Promoters, and Transcriptional Regulation in Three Types of Mouse Phospholipid Hydroperoxide Glutathione Peroxidase
J. Biochem., October 1, 2006; 140(4): 573 - 590.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Borchert, C. C. Wang, C. Ufer, H. Schiebel, N. E. Savaskan, and H. Kuhn
The Role of Phospholipid Hydroperoxide Glutathione Peroxidase Isoforms in Murine Embryogenesis
J. Biol. Chem., July 14, 2006; 281(28): 19655 - 19664.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Maiorino, A. Roveri, L. Benazzi, V. Bosello, P. Mauri, S. Toppo, S. C. E. Tosatto, and F. Ursini
Functional Interaction of Phospholipid Hydroperoxide Glutathione Peroxidase with Sperm Mitochondrion-associated Cysteine-rich Protein Discloses the Adjacent Cysteine Motif as a New Substrate of the Selenoperoxidase
J. Biol. Chem., November 18, 2005; 280(46): 38395 - 38402.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Conrad, S. G. Moreno, F. Sinowatz, F. Ursini, S. Kolle, A. Roveri, M. Brielmeier, W. Wurst, M. Maiorino, and G. W. Bornkamm
The Nuclear Form of Phospholipid Hydroperoxide Glutathione Peroxidase Is a Protein Thiol Peroxidase Contributing to Sperm Chromatin Stability
Mol. Cell. Biol., September 1, 2005; 25(17): 7637 - 7644.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Banning, S. Deubel, D. Kluth, Z. Zhou, and R. Brigelius-Flohe
The GI-GPx Gene Is a Target for Nrf2
Mol. Cell. Biol., June 15, 2005; 25(12): 4914 - 4923.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Bierl, B. Voetsch, R. C. Jin, D. E. Handy, and J. Loscalzo
Determinants of Human Plasma Glutathione Peroxidase (GPx-3) Expression
J. Biol. Chem., June 25, 2004; 279(26): 26839 - 26845.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. S. Jin, S. Baek, H. Lee, M. Y. Oh, Y. E. Koo, M. S. Shim, S. Y. Kwon, I. Jeon, S. Y. Park, K. Baek, et al.
A DNA replication-related element downstream from the initiation site of Drosophila selenophosphate synthetase 2 gene is essential for its transcription
Nucleic Acids Res., April 30, 2004; 32(8): 2482 - 2493.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/36/34286    most recent
M305327200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maiorino, M.
Right arrow Articles by Flohé, L.
Right arrow Search for Related Content
PubMed